Controlling hyperglycemia as an adjunct to cancer therapy.
about
Is there a role for carbohydrate restriction in the treatment and prevention of cancer?Hyperglycemia as a risk factor for cancer progressionPreoperative glycemic control status as a significant predictor of biochemical recurrence in prostate cancer patients after radical prostatectomyGenetic analysis of the Warburg effect in yeast.An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells.Does cancer risk increase with HbA1c, independent of diabetes?Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.The impact of type 2 diabetes and antidiabetic drugs on cancer cell growthDiabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation.Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study.The double trouble of metabolic diseases: the diabetes-cancer link.Yeast and cancer cells - common principles in lipid metabolism.Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal typeDiabetes and risk of cancer.Promoting a healthy lifestyle among cancer survivors.Glucose as a prognostic factor in ovarian carcinoma.Metformin for the Prevention of Bladder Cancer Recurrence: Is it Effective?Poor Preoperative Glycemic Control Is Associated with Dismal Prognosis after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Korean Multicenter Study.Diabetes, gestational diabetes and the risk of cancer in women: epidemiologic evidence and possible biologic mechanisms.Diabetes mellitus: influences on cancer risk.Insulin, insulin receptors, and cancer.FOXO transcription factors at the interface of metabolism and cancer.Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer.Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas.Persistent outpatient hyperglycemia is independently associated with survival, recurrence and malignant degeneration following surgery for hemispheric low grade gliomas.Survival benefits in colorectal adenocarcinoma with the use of metformin among a black diabetic inner city population.Prognostic Significance of Hyperglycemia in Patients with Brain Tumors: a Meta-Analysis.
P2860
Q21245058-73D06313-5887-4CDA-B793-16D8EBA9957FQ27687614-C7395D9B-8986-427C-8D20-576D8E4B31BEQ28546623-F9BB8748-A25B-48D1-B0FC-27D67DD26789Q30353146-A310258D-E521-4991-B169-61EA84D5E0DAQ33299761-ADA950F1-5D18-48F7-BF73-4B4A214B9E04Q33555255-CEC685E0-DD4D-466B-9B09-AB2525DB1DCBQ33692555-DF6E3181-F73C-4F4B-831D-6AFB2C321A89Q34095570-F40EFC45-9303-43EB-BD1C-469EB3D5463CQ34543788-D699E06A-A1C8-4AD6-BF45-C30107636724Q34660089-F0D6F994-0940-4DE9-B985-BA6A4FD7A5B4Q36058422-A83611ED-4536-4AC9-A2E2-6974AC5384A5Q36546961-032F04FF-F65D-49F3-A79D-AC4D64D7C345Q36594091-4F85BD5B-74DC-4FE5-B609-B69A0FF8EB95Q36637909-BC3B6E8E-B792-46DA-B5C9-41968791F8DBQ36657305-E96D95FE-F15D-4454-B077-BB61768483A9Q37114344-DA10A3EE-11DC-4EA2-BA39-484F14FC8A97Q37171698-8F55C7C3-2098-48D2-A0B8-1ED916E0B0FCQ37367482-5DA724B2-3FE3-441C-B1CB-BE0A22E8BFC7Q37853559-6EBBB79F-3D3B-41CC-A6A8-8E249F3DA99BQ38232006-15B06C38-4317-4C9D-A45A-5ECB4126DEA5Q38883620-D7EEFF3B-740C-4104-81DF-BD49A775B985Q39385262-2394A544-2837-4526-A7CE-57A2987E1C15Q40903985-58E9474B-5C04-4B6B-A641-2065F447E805Q44281661-5E0DEEDE-5031-4CFA-BED8-F5B754F6B1F2Q45934089-D3309465-A578-47EE-A433-BD507B67DBEFQ47133179-05FAAD3E-A5ED-49A8-8DBA-F8194686B49BQ48325616-EC539BE2-56B8-476F-A412-3732B37451A5
P2860
Controlling hyperglycemia as an adjunct to cancer therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Controlling hyperglycemia as an adjunct to cancer therapy.
@ast
Controlling hyperglycemia as an adjunct to cancer therapy.
@en
type
label
Controlling hyperglycemia as an adjunct to cancer therapy.
@ast
Controlling hyperglycemia as an adjunct to cancer therapy.
@en
prefLabel
Controlling hyperglycemia as an adjunct to cancer therapy.
@ast
Controlling hyperglycemia as an adjunct to cancer therapy.
@en
P2860
P356
P1476
Controlling hyperglycemia as an adjunct to cancer therapy.
@en
P2093
Cheryl A Krone
John T A Ely
P2860
P356
10.1177/1534735404274167
P577
2005-03-01T00:00:00Z